Phil Wiffen

2.0k total citations · 1 hit paper
39 papers, 1.4k citations indexed

About

Phil Wiffen is a scholar working on Geriatrics and Gerontology, General Health Professions and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Phil Wiffen has authored 39 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Geriatrics and Gerontology, 14 papers in General Health Professions and 7 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Phil Wiffen's work include Pharmaceutical Practices and Patient Outcomes (15 papers), Health Sciences Research and Education (7 papers) and Pain Management and Placebo Effect (6 papers). Phil Wiffen is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (15 papers), Health Sciences Research and Education (7 papers) and Pain Management and Placebo Effect (6 papers). Phil Wiffen collaborates with scholars based in United Kingdom, Sweden and China. Phil Wiffen's co-authors include Martin R. Tramèr, Dawn Carroll, H J McQuay, Andrew Moore, Tiina Saarto, Erwin Brown, Peter Davey, J. A. Roberts, G. Duckworth and B. Cookson and has published in prestigious journals such as Pain, Journal of Neurology Neurosurgery & Psychiatry and The Lancet Infectious Diseases.

In The Last Decade

Phil Wiffen

31 papers receiving 1.3k citations

Hit Papers

A systematic review of antidepressants in neuropathic pain 1996 2026 2006 2016 1996 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. A systematic review of antidepressants in neuropathic pain
    1996 659 citations H J McQuay, Martin R. Tramèr et al. Pain profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Phil Wiffen United Kingdom 8 511 289 203 201 200 39 1.4k
Caterina Aurilio Italy 22 487 1.0× 288 1.0× 255 1.3× 147 0.7× 84 0.4× 95 1.7k
Maria Beatrice Passavanti Italy 20 279 0.5× 219 0.8× 215 1.1× 119 0.6× 94 0.5× 96 1.3k
Maria Caterina Pace Italy 26 442 0.9× 422 1.5× 384 1.9× 139 0.7× 163 0.8× 149 2.4k
Jim Xiang United States 22 498 1.0× 492 1.7× 230 1.1× 178 0.9× 54 0.3× 61 1.9k
Pasquale Sansone Italy 20 193 0.4× 194 0.7× 169 0.8× 61 0.3× 89 0.4× 89 1.1k
Samad EJ Golzari Iran 26 212 0.4× 94 0.3× 480 2.4× 104 0.5× 155 0.8× 126 2.2k
Che Suraya Zin Malaysia 14 160 0.3× 155 0.5× 196 1.0× 77 0.4× 56 0.3× 34 753
Vincenzo Pota Italy 17 206 0.4× 173 0.6× 194 1.0× 95 0.5× 50 0.3× 74 913
Filomena Puntillo Italy 22 117 0.2× 355 1.2× 174 0.9× 60 0.3× 228 1.1× 58 1.7k
Pavlos Myrianthefs Greece 23 208 0.4× 138 0.5× 38 0.2× 52 0.3× 170 0.8× 88 1.7k

Countries citing papers authored by Phil Wiffen

Since Specialization
Citations

This map shows the geographic impact of Phil Wiffen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Phil Wiffen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Phil Wiffen more than expected).

Fields of papers citing papers by Phil Wiffen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Phil Wiffen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Phil Wiffen. The network helps show where Phil Wiffen may publish in the future.

Co-authorship network of co-authors of Phil Wiffen

This figure shows the co-authorship network connecting the top 25 collaborators of Phil Wiffen. A scholar is included among the top collaborators of Phil Wiffen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Phil Wiffen. Phil Wiffen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wiffen, Phil. (2018). Response from the Editor in Chief. European Journal of Hospital Pharmacy. 25(6). e4–e4.
2.
Wiffen, Phil. (2017). How to Publish in Biomedicine. 500 tips for success. European Journal of Hospital Pharmacy. 24(5). 311.2–312.
3.
Jenkins, Abi, Alison H. Thomson, Nicholas M. Brown, et al.. (2016). Amikacin use and therapeutic drug monitoring in adults: do dose regimens and drug exposures affect either outcome or adverse events? A systematic review. Journal of Antimicrobial Chemotherapy. 71(10). 2754–2759. 55 indexed citations
4.
Wiffen, Phil. (2016). Litt's Drug Eruption and Reaction Manual 22nd Edition. European Journal of Hospital Pharmacy. 23(4). 248.2–248. 1 indexed citations
5.
Wiffen, Phil & Andrew Moore. (2016). Pain leads the way: the development of evidence-based medicine for pain relief. International Journal of Clinical Pharmacology and Therapeutics. 54(7). 505–513. 2 indexed citations
6.
Lu, Hao, Tommy Eriksson, & Phil Wiffen. (2015). Chapter 9: Evidence based pharmacy for developing countries. European Journal of Hospital Pharmacy. 22(2). 66–72. 2 indexed citations
7.
Wiffen, Phil. (2014). No evidence or evidence of no effect. European Journal of Hospital Pharmacy. 21(2). 71–71. 1 indexed citations
8.
Wiffen, Phil. (2014). Working on the front line: how do you cope?. European Journal of Hospital Pharmacy. 21(6). 319–319. 1 indexed citations
9.
Wiffen, Phil. (2013). Get writing!. European Journal of Hospital Pharmacy. 20(1). 2–2. 1 indexed citations
10.
Wiffen, Phil, Tommy Eriksson, & Hao Lu. (2013). CHAPTER 2 introduction to evidence-based practice in evidence-based pharmacy 2nd edition. European Journal of Hospital Pharmacy. 20(6). 324–327. 7 indexed citations
11.
Saarto, Tiina & Phil Wiffen. (2010). Antidepressants for neuropathic pain: a Cochrane review. Journal of Neurology Neurosurgery & Psychiatry. 81(12). 1372–1373. 108 indexed citations
12.
Stone, Sheldon P., Ben S. Cooper, C Kibbler, et al.. (2007). The ORION statement: guidelines for transparent reporting of outbreak reports and intervention studies of nosocomial infection. The Lancet Infectious Diseases. 7(4). 282–288. 234 indexed citations
13.
Stone, S., Ben S. Cooper, C Kibbler, et al.. (2007). The ORION statement: guidelines for transparent reporting of Outbreak Reports and Intervention studies Of Nosocomial infection. Journal of Antimicrobial Chemotherapy. 59(5). 833–840. 103 indexed citations
14.
Stone, S., C C Kibbler, Jacqueline Roberts, et al.. (2006). P7.02 The ORION Statement: a CONSORT Equivalent for Infection Control Studies - Guidelines for Transparent Reporting of Outbreak Reports and Intervention Studies of Nosocomial Infection. Journal of Hospital Infection. 64. S40–S40. 1 indexed citations
15.
Wiffen, Phil. (2003). The Cochrane Pain, Palliative and Supportive Care Group: life history of a Cochrane review. Palliative Medicine. 17(8). 719–720. 1 indexed citations
16.
Wiffen, Phil. (2003). The Cochrane Pain, Palliative and Supportive Care Group: scope and challenges. Palliative Medicine. 17(3). 232–234. 1 indexed citations
17.
Wiffen, Phil. (2003). The Cochrane Collaboration: pain, palliative and supportive care. Palliative Medicine. 17(1). 75–77. 4 indexed citations
18.
McQuay, H J, et al.. (1996). A systematic review of antidepressants in neuropathic pain. Pain. 68(2). 217–227. 659 indexed citations breakdown →
19.
Wiffen, Phil & R Andrew Moore. (1996). Demonstrating effectiveness–the concept of numbers-needed-to-treat. Journal of Clinical Pharmacy and Therapeutics. 21(1). 23–27. 2 indexed citations
20.
Wiffen, Phil & R Andrew Moore. (1996). Demonstrating effectiveness-the concept of numbers-needed-to-treat. Journal of Clinical Pharmacy and Therapeutics. 21(1). 23–27. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Caterina Aurilio Breakdown of academic impact, for papers by Maria Beatrice Passavanti Breakdown of academic impact, for papers by Maria Caterina Pace Breakdown of academic impact, for papers by Jim Xiang Breakdown of academic impact, for papers by Pasquale Sansone Breakdown of academic impact, for papers by Samad EJ Golzari Breakdown of academic impact, for papers by Che Suraya Zin Breakdown of academic impact, for papers by Vincenzo Pota Breakdown of academic impact, for papers by Filomena Puntillo Breakdown of academic impact, for papers by Pavlos Myrianthefs
Rankless by CCL
2026